The inception of the African Constituency Bureau (ACB) in 2017 marked a pivotal moment for the African continent’s engagement with the Global Fund instances. This transformative initiative stemmed from a collective will and commitment among African Health ministers who convened in Johannesburg, South Africa, in 2012. Their vision was to establish an office that would facilitate African representation and participation within the Global Fund’s Board and committees, a vision that has since evolved into a dynamic force for change.
Situated in Addis Ababa, Ethiopia, under the auspices of the UNDP Regional Service Center for Africa, the ACB has grown from a modest start of five staff members to a robust team of eleven dedicated professionals. This growth mirrors the substantial achievements and milestones that have been accomplished over the past five years. The ACB has succeeded in fostering a vibrant African health community, vigorously advocating for African interests, elevating African priorities, and building a coalition of stakeholders committed to improving health outcomes on the continent. Yet, this journey is far from over; it remains a work in progress with boundless potential.
Comprising a Secretariat led by an accomplished Executive Director and overseen by a Board composed of representatives from East and Southern Africa (ESA) and West and Central Africa (WCA) countries, the ACB is a powerful voice for all 47 African nations receiving Global Fund support in the fight against HIV, TB, and malaria. Its membership showcases diversity and inclusivity, spanning government officials, civil society leaders, technical experts, and community of practice advocates. This eclectic network of partners bolsters the ACB’s capacity and contributes invaluable insights and expertise to Africa’s battle against these diseases.
The ACB stands as Africa’s advocate in the realm of global health diplomacy. Through its provision of policy guidance, evidence-based advocacy, and technical assistance, the ACB brings about tangible positive changes, shaping policies, influencing decision-making processes, and championing the health agenda of the African continent. Click & Tweet! This collaborative effort with partners embodies a commitment to a healthier, more prosperous Africa, while actively contributing to the global mission of eradicating HIV, TB, and malaria by 2030. It is a shared journey towards reshaping healthcare in Africa and beyond.
As the ACB commemorated its 5th anniversary in 2022, the spirit of passion and determination remained unwavering. In 2023, a new chapter unfolds, marked by a significant move to the Africa CDC compound. This relocation is not just about geography; it signifies closer proximity to the heart of African health efforts, enabling the ACB to better serve the continent. Gratitude is extended to the ACB Board Chair, Dr. Jean Jacques Mbungani, the ACB Board members, Mr. Josephat Kakoma, the Executive Director, and H. E. Dr. Jean Kaseya Director General of the Africa CDC, whose partnership has made this move possible.
The year 2023 signifies a fresh chapter for the ACB, characterized by the same unwavering commitment to its mission. With a history of accomplishments behind it and a future brimming with potential, the ACB continues to stand as a beacon of progress, collaboration, and transformation in Africa’s health landscape. Together, let us embark on this journey to shape the destiny of healthcare for Africa
Armelle Nyobe
1 Comment